Eric Karran
AbbVie (United States)(US)Cambridge Scientific (United States)(US)University College London(GB)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Cholinesterase and Neurodegenerative Diseases, Neuroinflammation and Neurodegeneration Mechanisms, Computational Drug Discovery Methods, Dementia and Cognitive Impairment Research
Most-Cited Works
- → The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics(2011)2,182 cited
- → A Human Homolog of Angiotensin-converting Enzyme(2000)2,018 cited
- → The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes(2012)1,926 cited
- → The Cellular Phase of Alzheimer’s Disease(2016)1,887 cited
- → The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques(2019)950 cited
- → The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics(2022)660 cited